(ARBE) Arbe Robotics - Overview
Sector: Technology | Industry: Scientific & Technical Instruments | Exchange: NASDAQ (USA) | Market Cap: 143m USD | Total Return: -36.1% in 12m
Avg Turnover: 2.75M
Qual. Beats: 1
Rev. Trend: -72.6%
Qual. Beats: 0
Warnings
Share dilution 37.8% YoY
Interest Coverage Ratio -105.5 is critical
Altman Z'' -15.00 < 1.0 - financial distress zone
Fakeout Below Avwap Earnings
Tailwinds
No distinct edge detected
Arbe Robotics Ltd. is a semiconductor firm specializing in 4D imaging radar technology for the automotive and industrial sectors. Headquartered in Israel, the company designs and develops high-resolution radar chipsets-comprising transmitter, receiver, and processor components-alongside its proprietary Phoenix perception radar system. These solutions are engineered to support Advanced Driver Assistance Systems (ADAS) and Autonomous Vehicle (AV) suites by providing high-fidelity spatial mapping and object tracking.
The company operates within the Tier 2 automotive supplier framework, providing core hardware and software stacks to Tier 1 integrators and original equipment manufacturers (OEMs). 4D imaging radar represents a critical technological shift in the industry, as it provides elevation data and superior performance in adverse weather conditions compared to traditional 2D radar or lidar systems. This technology is increasingly viewed as essential for achieving Level 3 and higher vehicle autonomy.
For a detailed analysis of the companys competitive positioning, consider reviewing the additional metrics available on ValueRay. Arbe Robotics currently maintains a global footprint with operations spanning major automotive hubs in North America, Europe, and Asia.
- Tier 1 automotive supplier design wins drive mass production revenue
- Global ADAS regulatory mandates accelerate 4D imaging radar adoption
- Shift from development stage to high-volume chipset manufacturing improves margins
- Geopolitical instability in Israel impacts operational continuity and supply chain
- Cash burn rate necessitates additional capital raises or strategic partnerships
| Net Income: -46.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.52 > 0.02 and ΔFCF/TA 2.99 > 1.0 |
| NWC/Revenue: 3.82k% < 20% (prev 2.76k%; Δ 1.06k% < -1%) |
| CFO/TA -0.51 > 3% & CFO -38.1m > Net Income -46.4m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (112.9m) vs 12m ago 37.78% < -2% |
| Gross Margin: -78.17% > 18% (prev -1.02%; Δ -7.71k% > 0.5%) |
| Asset Turnover: 1.52% > 50% (prev 1.26%; Δ 0.25% > 0%) |
| Interest Coverage Ratio: -105.5 > 6 (EBITDA TTM -47.7m / Interest Expense TTM 457k) |
| A: 0.53 (Total Current Assets 71.8m - Total Current Liabilities 32.5m) / Total Assets 74.6m |
| B: -4.00 (Retained Earnings -298.1m / Total Assets 74.6m) |
| C: -0.71 (EBIT TTM -48.2m / Avg Total Assets 67.7m) |
| D: -8.82 (Book Value of Equity -298.1m / Total Liabilities 33.8m) |
| Altman-Z'' = -23.63 = D |
As of May 31, 2026, the stock is trading at USD 1.10 with a total of 6,052,289 shares traded.
Over the past week, the price has changed by -7.56%,
over one month by +47.08%,
over three months by +33.77% and
over the past year by -36.05%.
Arbe Robotics has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ARBE.
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 2.4 | 116.4% |
P/S = 139.266
P/B = 3.8746
Revenue TTM = 1.03m USD
EBIT TTM = -48.2m USD
EBITDA TTM = -47.7m USD
Long Term Debt = 2.47m USD (estimated: total debt 27.9m - short term 25.4m)
Short Term Debt = 25.4m USD (from shortTermDebt, last quarter)
Debt = 29.9m USD (from shortLongTermDebtTotal, last quarter) + Leases 2.03m
Net Debt = -15.1m USD (calculated: Debt 29.9m - CCE 45.0m)
Enterprise Value = 127.8m USD (142.9m + Debt 29.9m - CCE 45.0m)
Interest Coverage Ratio = -105.5 (Ebit TTM -48.2m / Interest Expense TTM 457k)
EV/FCF = -3.33x (Enterprise Value 127.8m / FCF TTM -38.4m)
FCF Yield = -30.06% (FCF TTM -38.4m / Enterprise Value 127.8m)
FCF Margin = -3.75k% (FCF TTM -38.4m / Revenue TTM 1.03m)
Net Margin = -4.52k% (Net Income TTM -46.4m / Revenue TTM 1.03m)
Gross Margin = -78.17% ((Revenue TTM 1.03m - Cost of Revenue TTM 1.83m) / Revenue TTM)
Gross Margin QoQ = -16.59% (prev -95.67%)
Tobins Q-Ratio = 1.71 (Enterprise Value 127.8m / Total Assets 74.6m)
Interest Expense / Debt = 1.53% (Interest Expense 457k / Debt 29.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = -38.1m (EBIT -48.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.21 (Total Current Assets 71.8m / Total Current Liabilities 32.5m)
Debt / Equity = 0.73 (Debt 29.9m / totalStockholderEquity, last quarter 40.8m)
Debt / EBITDA = 0.32 (negative EBITDA) (Net Debt -15.1m / EBITDA -47.7m)
Debt / FCF = 0.39 (negative FCF - burning cash) (Net Debt -15.1m / FCF TTM -38.4m)
Total Stockholder Equity = 53.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -68.57% (Net Income -46.4m / Total Assets 74.6m)
RoE = -13.21% (Net Income TTM -46.4m / Total Stockholder Equity 351.5m)
RoCE = -13.62% (EBIT -48.2m / Capital Employed (Equity 351.5m + L.T.Debt 2.47m))
RoIC = -169.2% (out of range, set to none) (NOPAT -38.1m / Invested Capital 22.5m)
WACC = 12.59% (E(142.9m)/V(172.8m) * Re(14.97%) + D(29.9m)/V(172.8m) * Rd(1.53%) * (1-Tc(0.21)))
Discount Rate = 14.97% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 100.00 | Cagr: 18.22%
[DCF] Fair Price = unknown (Cash Flow -38.4m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 4.0 | # QB: 1
Revenue Correlation: -72.55 | Revenue CAGR: -26.15% | SUE: -0.15 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.07 | Chg30d=+26.32% | Revisions=+20% | Analysts=1
EPS current Year (2026-12-31): EPS=-0.27 | Chg30d=+0.00% | Revisions=+20% | GrowthEPS=+12.9% | GrowthRev=+338.6%
EPS next Year (2027-12-31): EPS=-0.14 | Chg30d=+30.00% | Revisions=+20% | GrowthEPS=+48.1% | GrowthRev=+478.2%